Top Markets
Coin of the day
Reviva Pharmaceuticals Holdings, Inc. Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc.

RVPHW
Rangering i aksjer #39800
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical... Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for diseases with substantial unmet medical needs. Their pipeline targets disorders within the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory disease categories. The company's leading drug candidate, brilaroxazine (RP5063), is currently in Phase III clinical trials for the treatment of schizophrenia. This compound has also completed Phase I trials for a diverse set of conditions, including bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, the behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. Furthermore, Reviva is advancing RP1208, which is in pre-clinical development for depression and obesity. Founded in 2018, the company is headquartered in Cupertino, California.
Aksjekurs
$0.003
Sist synkronisert: 2025-12-12
Markedsverdi
$343.91K
Endring (1 dag)
-16.67%
Endring (1 år)
-90.23%
Land
US
Handel Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Kategori

Utbyttehistorikk for Reviva Pharmaceuticals Holdings, Inc. (RVPHW)
Reviva Pharmaceuticals Holdings, Inc. (aksjesymbol: RVPHW) har gitt totalt 0 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): 0.00
Utbytteavkastning (TTM): 0
Utbyttebetalinger for Reviva Pharmaceuticals Holdings, Inc. (RVPHW) fra 2026 til 2026
Årlige utbyttebetalinger
År Utbytte (justert for aksjesplitt) Endre
Ikke nok data for de angitte datoene.
Liste over alle utbyttebetalinger
År Utbytte Endre
Ikke nok data for de angitte datoene.
Utbyttebetalinger for lignende selskaper eller konkurrenter
Selskap Antall utbyttebetalinger Land
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
29.00%
BE